ACYP2 functions as an innovative nano-therapeutic target to impede the progression of hepatocellular carcinoma by inhibiting the activity of TERT and the KCNN4/ERK pathway
Article in Journal of Nanobiotechnology (September 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in Journal of Nanobiotechnology (September 2024)
Article in Molecular & Cellular Proteomics (August 2023)
Article in Drug Resistance Updates (May 2023)